SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Recruiting	Not stated	2026-10-08		NCT07341321

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Klinikum Wels-Grieskirchen	2
Krankenhaus der Barmherzigen Brüder St. Veit/Glan	1
Medical University of Graz	112
Ordensklinikum Linz GmbH Krankenhaus Barmherzige Schwestern	2
University Hospital St. Polten	4

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Klinikum Wels-Grieskirchen	Wels	Austria	2
Krankenhaus der Barmherzigen Brüder St Veit an der Glan	Sankt Veit an der Glan	Austria	1
Medical University of Graz	Graz	Austria	14
Ordensklinikum Linz	Linz	Austria	8
University Hospital St. Pölten	Sankt Pölten	Austria	2